Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Reminder: Invitation to Roche Analyst Event at ASH 2016 Dienstag, 22. November 2016 - 14:10

Roche - Investor Update

Basel, 22 November 2016
visual.jpg
We are pleased to invite you to an analyst briefing to discuss data presented on Roche Group's hematology portfolio at the American Society of Hematology Annual Meeting (ASH) in San Diego (3 - 6 December 2016).
Meeting information 
Date: 
Monday, 5 December 2016
Time (PST): 
5:30pm Registration desk opens
6:00pm Start of meeting
7:30pm End of meeting followed by a buffet reception
> Download to my calendar (download to your calendar will be in local time San Diego)
Venue 
The Westin San Diego
Meeting room: Topaz, 2nd Floor
400 W Broadway
San Diego, California 92101 
USA
> map
Presenters: 
  • Nancy Valente, M.D., Vice President, Product Development Hematology/Oncology
  • David Traub, M.D., Lifecycle Leader anti-CD20 Franchise
  • Reema Mewar, Ph.D., Lifecycle Leader Venclexta/Venclyxto
  • Michael Wenger, M.D., Senior Group Medical Director Polatuzumab vedotin
To register for the event, please follow the link (Password: Analyst2016).
Dial in to the conference 10-15 minutes prior to the scheduled start, using the following dial-in numbers (listen-only mode, no live-access to speakers):
+41 (0)58 310 50 00 (Europe and ROW) or
+44 (0)203 059 58 62 (UK) or
+1 (1)631 570 5613 (USA)

To expedite the registration process on the day of the conference call, you may pre-register for the event. > click here
Alternatively a live audio webcast can be accessed via http://ir.roche.com. The presentation slides will be available from the IR website at http://ir.roche.com following to the closure of the ASH meeting.
A replay of the webcast will be available on demand on the Roche website. > click here
Best regards, 
Dr. Karl Mahler
Head of Investor Relations
 
Dr. Bruno Eschli
Investor Relations Officer
Up
Roche Investor Relations
Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com
Dr. Sabine Borngräber 
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com
Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com
 
Investor Relations North America
Neera Dahiya Ravindran, MD 
Phone: +1 650 491 5281 
e-mail: ravindran.neera@gene.com
Loren Kalm 
Phone: +1 650 225 3217 
e-mail: kalm.loren@gene.com
22 November 2016      Content owner: Roche Investor Relations    ©2016 F. Hoffmann-La Roche Ltd.